Cannabis Central: Pure-Play Pot Stock Portfolio Performance UP Slightly On Wednesday

The Pure-Play Pot Stock Portfolio consists of the 25 pure-play* cannabis stocks that trade for more than US$1/share and it was UP 1.5% on Wednesday with 15 of the constituents going UP, 9 going down, and 1 with No Change in price. In addition, 3 of the 4 industry categories in which they operate went UP as well. The details are as follows:

Wednesday's Major Winners and Losers

• 4 stocks advanced by 5% or more, namely:
  1. Organigram (OGI) +7.4% (announced intent to introduce an 18% THC dried flower product)
  2. Tilray (TLRY) +6.6%
  3. Neptune (NEPT) +5.8%  (named one of Canada's top 3-year price appreciation & revenue growth companies)
  4. Cresco (CRLBF) +5.3% (announced expansion of leadership team with 3 senior promotions to accelerate growth)
• 2 stocks declined by 5% or more, namely: 
  1. Columbia (CCHWF) -6.7%
  2. Avicanna (AVCNF) -5.7%

The 25 munKNEE Pure-Play Pot Stock Portfolio includes companies doing business in 4 categories based on their primary area of focus in the cannabis industry. The categories are identified below with how they performed given the performance of the stocks in the portfolio that make up each category:

1. The Vertically Integrated (i.e. Seed-to-Sale) Category has 21 portfolio participants that grow, process, and sell cannabis and hemp flower and related products and it was only UP 1.5%.
   • the 7 Canadian Licensed Producer (LPs) portfolio participants  (ACB; CGC; CRON; OGI; ROMJF and TLRY) went UP 1.0%, on average.
   • the 12 cannabis U.S. Multi-State Operator (MSOs) portfolio participants (ACRGF; AYRSF; CCHWF; CRLBF; CURLF;   GTBIF; HRVSF; JUSHF; PLNHF; SHWZ; TCNNF and TRSSF) went UP 1.8%, on average.
   • the 2 hemp seed-to-sale MSO portfolio participants (CWBHF and  YCBD) were UNCHANGED in price, on average.
2. The Extraction Category has 2 portfolio participants (NEPT and VLNCF) focused on the extraction of cannabis compounds and their infusion into consumer products and they went UP 2.6%, on average.
3. The Consumption Devices Category has only 1 portfolio participant  (GNLN) focused on developing and selling personal consumption devices for cannabis consumers such as vape pens and inhalers and it went UP 4.3% in price.
4. The Biotechnology Category has only 1 portfolio participant (AVCNF) which markets new drugs utilizing cannabinoids (CBD) and it went DOWN 5.7%.

*Please note: The 25 pure-play stocks in the munKNEE Pure-Play Pot Stock Portfolio are just that, pure, deriving 100% of their revenue from the sale of recreational and medicinal cannabis and consumption-related products and, as such, it reflects the true health of the marijuana industry in the U.S. and Canada.